8 companies including JW Joongwae have entered acquisition competition of DreamPharma

Published: 2014-04-30 13:17:41

Updated: 2014-04-30 13:17:41

JW Joongwae and companies with private equity fund investment have entered acquisition competition of DreamPharma which is a subsidiary of Hanwha Group.

According to the investment banking industry, 8 companies including JW Joongwae and Stic Investment participated in a pre-tender of DreamPharma which was conducted by Hanwha Chemical and Citi Global Market Securities on Apr 28.

Hanwha Chemica...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.